Biotech Firm Nuritas, Backed By U2’s Bono & The Edge, Raises $45M to “Improve Human Health” With Plants
Dublin’s Nuritas, a biotechnology company that includes U2’s Bono and The Edge as early investors, has secured $45 million in Series B, bringing its total raise to $75 million. The company has developed a peptide for skin health discovered in peas, and a peptide discovered in fava beans that supports muscle health, both due for market launch in 2022. Nuritas states its mission is to “firstly manage and improve human health and secondly help make our food system more sustainable by replacing current unwanted ingredients and molecules with more natural and sustainable ones.” The company claims it has established the world’s largest peptide knowledge base using a proprietary AI and genomics platform called Nπϕ™ (Nuritas Peptide Finder), which has attracted high-profile partnerships including Nestle, Mars, …